Saltar al contenido
Merck

Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity.

Nature immunology (2021-08-25)
Wei Hu, Zhong-Min Wang, Yongqiang Feng, Michail Schizas, Beatrice E Hoyos, Joris van der Veeken, Jacob G Verter, Regina Bou-Puerto, Alexander Y Rudensky
RESUMEN

The immunosuppressive function of regulatory T (Treg) cells is dependent on continuous expression of the transcription factor Foxp3. Foxp3 loss of function or induced ablation of Treg cells results in a fatal autoimmune disease featuring all known types of inflammatory responses with every manifestation stemming from Treg cell paucity, highlighting a vital function of Treg cells in preventing fatal autoimmune inflammation. However, a major question remains whether Treg cells can persist and effectively exert their function in a disease state, where a broad spectrum of inflammatory mediators can either inactivate Treg cells or render innate and adaptive pro-inflammatory effector cells insensitive to suppression. By reinstating Foxp3 protein expression and suppressor function in cells expressing a reversible Foxp3 null allele in severely diseased mice, we found that the resulting single pool of rescued Treg cells normalized immune activation, quelled severe tissue inflammation, reversed fatal autoimmune disease and provided long-term protection against them. Thus, Treg cells are functional in settings of established broad-spectrum systemic inflammation and are capable of affording sustained reset of immune homeostasis.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Roche
ADNasa I, grade II, from bovine pancreas
Sigma-Aldrich
Tamoxifeno, ≥99%
Sigma-Aldrich
Forbol 12-miristato 13-acetato, ≥99% (TLC), film or powder
Sigma-Aldrich
(Z)-4-Hydroxytamoxifen, ≥98% Z isomer
Sigma-Aldrich
Ácido etilenodiaminotetraacético disodium salt dihydrate, ACS reagent, 99.0-101.0%
Sigma-Aldrich
Brefeldin A, ≥99% (HPLC and TLC), BioXtra, for molecular biology